You are here

Article info

Article menu
Download PDFPDF
IV-Preliminary Results
220 Safety of multiple sclerosis patients treated by natalizumab (Network EDMUS)

Authors

  1. Correspondence to Sandra Vukusic, Service de Neurologie A et EDMUS, Centre de Coordination pour la SEP, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69 Lyon, France; sandra.vukusic{at}chu-lyon.fr

Citation

Vukusic S, Passante N, Ritleng C, et al
220 Safety of multiple sclerosis patients treated by natalizumab (Network EDMUS)
Quality and Safety in Health Care 2010;19:A179-A180.

Publication history

  • First published September 23, 2015.
Online issue publication 
May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.